| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.01 | 0.9 |